162 filings
Page 3 of 9
8-K
tw1jr
10 May 12
Entry into a Material Definitive Agreement
12:00am
ARS
hh6nw2xrh4r24
8 May 12
Annual report to shareholders
12:00am
8-K
eiqy5rrag4
7 May 12
Regulation FD Disclosure
12:00am
EFFECT
ttus0f6c y8
26 Apr 12
Notice of effectiveness
12:00am
DEFA14A
z628rnxy
24 Apr 12
Additional proxy soliciting materials
12:00am
8-K
k3i0wzlu4vq2wsy2z1
20 Apr 12
PROLOR Biotech Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
12:00am
8-K
deuh9u vqtli324
19 Apr 12
Long Acting Reversible PEGylated Oxyntomodulin - MOD - 6030 Apr 2012 5th Diabetes Drug Discovery & Development Conference
12:00am
S-3
6ovl6i spev3ji
6 Apr 12
Shelf registration
12:00am
8-K
4tvkgwd7ue0
24 Feb 12
Regulation FD Disclosure
12:00am
8-K
57l4gd2n1twhqco5
9 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
b1wdmu4u35sq ca6llax
28 Apr 11
Additional proxy soliciting materials
12:00am
8-K
dhak0
14 Apr 11
Departure of Directors or Certain Officers
12:00am